What's new? Log in Free sign up

IMV (IMVIF)

Company Profile

Company profile

Ticker

IMVIF

Exchange

Website

www.imv-inc.com

CEO

Mr. Andrew Hall M.Sc.

Incorporated

Canada (Federal)

Location

Nova Scotia, Canada

Fiscal year end

Sector

Health Technology > Biotechnology

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Alabama Power • Mississippi Power • Teva Pharmaceutical Industries Limited • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb • Viatris ...

Former names

Immunovaccine Inc.

SEC CIK

Corporate docs

Underwriting Agreements

IMVIF stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Securities registration termination

Automatic registration of securities (post-effective amendment, Canada)

Automatic registration of securities (post-effective amendment, Canada)

Automatic registration of securities (post-effective amendment, Canada)

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

ARMISTICE CAPITAL, LLC

FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC

FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC

Venrock Healthcare Capital Partners II, L.P.

FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC

Beneficial ownership report (amended)

Financial summary

Financial statements Chart IMVIF financial data

Quarter (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from IMV earnings reports.

Institutional ownership, Q2 2024

IMVIF institutional ownership history Ownership history

37.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2	2	–
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	18.74 mm	18.74 mm	–
Total shares	3.80 mm	3.80 mm	–
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Venrock Healthcare Capital Partners II	3.15 mm	$18.74 mm	0.0%
Fonds De Solidarite Des Travailleurs Du Quebec	654.01 k	$0.00	0.0%

Largest transactions	Shares	Bought/sold	Change
Fonds De Solidarite Des Travailleurs Du Quebec	654.01 k	0.00	0.0%
Venrock Healthcare Capital Partners II	3.15 mm	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.